Angela Huttner
How representative is a point-of-care randomized trial? Clinical outcomes of patients excluded from a point-of-care randomized controlled trial evaluating antibiotic duration for Gram-negative bacteraemia: a multicentre prospective observational cohort study
Rossel A, Zandberg K, Albrich W, Huttner A. How representative is a point-of-care randomized trial? Clinical outcomes of patients excluded from a point-of-care randomized controlled trial evaluating antibiotic duration for Gram-negative bacteraemia: a multicentre prospective observational cohort study. Clin Microbiol Infect 2021; 28:297.e1-297.e6.
08.06.2021How representative is a point-of-care randomized trial? Clinical outcomes of patients excluded from a point-of-care randomized controlled trial evaluating antibiotic duration for Gram-negative bacteraemia: a multicentre prospective observational cohort study
08.06.2021Clin Microbiol Infect 2021; 28:297.e1-297.e6
Rossel Anne, Zandberg Kimberly P M, Albrich Werner, Huttner Angela
Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial
von Dach E, Bochud P, Kaiser L, Harbarth S, Rossel A, McCallin S, Lemmenmeier E, Kohler P, Huttner B, Gayet-Ageron A, Flury D, Cuvelier C, Prendki V, Brunel A, Albrich W, Huttner A. Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial. JAMA 2020; 323:2160-2169.
02.06.2020Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial
02.06.2020JAMA 2020; 323:2160-2169
von Dach Elodie, Bochud Pierre-Yves, Kaiser Laurent, Harbarth Stephan, Rossel Anne, McCallin Shawna, Lemmenmeier Eva, Kohler Philipp, Huttner Benedikt, Gayet-Ageron Angèle, Flury Domenica, Cuvelier Clémence, Prendki Virginie, Brunel Anne-Sophie, Albrich Werner, Huttner Angela
PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia
Huttner A, Albrich W, Bochud P, Gayet-Ageron A, Rossel A, Dach E, Harbarth S, Kaiser L. PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia. BMJ Open 2017; 7:e017996.
13.07.2017PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia
13.07.2017BMJ Open 2017; 7:e017996
Huttner Angela, Albrich Werner, Bochud Pierre-Yves, Gayet-Ageron Angèle, Rossel Anne, Dach Elodie von, Harbarth Stephan, Kaiser Laurent
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
Huttner A, Bernasconi E, Viereck V, Kavvadias T, Kling K, Ryu G, Hülder T, Gröger S, Scheiner D, Alaimo C, Harbarth S, Poolman J, Kuhn A, de Vallière S, Hatz C, van den Dobbelsteen G, Abbanat D, Hornacek A, Frölich R, Dreyer A, Martin P, Davies T, Fae K, van den Nieuwenhof I, Thoelen S, Fonck V. Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial. Lancet Infect Dis 2017; 17:528-537.
24.02.2017Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
24.02.2017Lancet Infect Dis 2017; 17:528-537
Huttner Angela, Bernasconi Enos, Viereck Volker, Kavvadias Tilemachos, Kling Kerstin, Ryu Gloria, Hülder Tanja, Gröger Sabine, Scheiner David, Alaimo Cristina, Harbarth Stephan, Poolman Jan, Kuhn Anette, de Vallière Serge, Hatz Christoph, van den Dobbelsteen Germie, Abbanat Darren, Hornacek Alena, Frölich Rahel, Dreyer Anita M, Martin Patricia, Davies Todd, Fae Kellen, van den Nieuwenhof Ingrid, Thoelen Stefan, Fonck Veronica Gambillara
Validation of IDSA/ATS Algorithm for Duration of Pneumonia Therapy
Albrich W, Huttner B, Huttner A. Validation of IDSA/ATS Algorithm for Duration of Pneumonia Therapy. JAMA Intern Med 2017; 177:283-284.
01.02.2017Validation of IDSA/ATS Algorithm for Duration of Pneumonia Therapy
01.02.2017JAMA Intern Med 2017; 177:283-284
Albrich Werner, Huttner Benedikt D, Huttner Angela